Literature DB >> 2526643

Native interleukin 1 inhibitors.

J W Larrick.   

Abstract

Much information has accumulated on the isolation and characterization of a heterogeneous group of molecules that inhibit one or more of the bioactivities of interleukin 1. In this review James Larrick discusses the biological and biochemical data available on several of these native interleukin 1 inhibitors, some of which have additional, unexpected activities.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2526643     DOI： 10.1016/0167-5699(89)90308-3

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  23 in total

1.  Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery.

Authors:  F Di Padova; C Pozzi; M J Tondre; R Tritapepe
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 2.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release.

Authors:  C Bernard; B Szekely; I Philip; E Wollman; D Payen; A Tedgui
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

4.  Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation.

Authors:  T Nishihara; Y Ohsaki; N Ueda; N Saito; G R Mundy
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  An interleukin-1 inhibitor in gingival crevicular fluid of patients with chronic inflammatory periodontal disease.

Authors:  H Kabashima; K Maeda; H Iribe; K Yamashita; T Hirofuji; Y Iwamoto; M Aono
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls.

Authors:  S Ruschen; W Stellberg; H Warnatz
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production.

Authors:  L Borish; M S King; J J Mascali; S Johnson; B Coll; L J Rosenwasser
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

Review 8.  Interleukins. Clinical pharmacokinetics and practical implications.

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

9.  Binding of cytokines to pharmaceutically prepared human immunoglobulin.

Authors:  M Svenson; M B Hansen; K Bendtzen
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis.

Authors:  C Aime; S Cohen-Kaminsky; S Berrih-Aknin
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.